Literature DB >> 21690093

Delineation of the role of Toll-like receptor signaling during peritonitis by a gradually growing pathogenic Escherichia coli.

Cornelis van 't Veer1, Petra S van den Pangaart, Daniëlle Kruijswijk, Sandrine Florquin, Alex F de Vos, Tom van der Poll.   

Abstract

In a mouse model of Escherichia coli sepsis characterized by a primary peritoneal infection with 10(4) E. coli and a gradually growing bacterial load, we here show that the early cytokine response and antibacterial defense are dominated by TLR4 via a cooperative action of MyD88 and Trif. Although MyD88(-/-) mice succumbed earlier than WT mice in this E. coli peritonitis model, Trif(-/-) mice displayed a small but significant survival advantage. Despite a large early deficit in antimicrobial defense, TLR4(-/-) mice showed an unaltered survival with normal neutrophil attraction to the peritoneal cavity and normal or even elevated late cytokine release. TLR2 compensated for the lack of TLR4 because TLR2(-/-)/TLR4(-/-) mice did show decreased neutrophil attraction and increased mortality compared with WT mice. Nearly normal early peritoneal TNFα production and lack of early counterregulating systemic levels of the chemoattractant KC were associated with normal peritoneal neutrophil attraction in TLR4(-/-) mice. Late stage increased TNF, IL-1β, IFN-β, and typical IFN-γ production in TLR4(-/-) mice prompted us to evaluate expression of the negative feedback regulator SOCS-1. Lack of early hepatic SOCS-1 expression in TLR4(-/-) mice explained the late innate production of IFN-γ by the liver in TLR4(-/-) mice in this low dose E. coli peritonitis model. In contrast, early TLR4-induced IFN-γ production is described as a hallmark in high dose E. coli peritonitis models. The present study displays how the kinetics of pro- and anti-inflammatory mechanisms are regulated by TLRs during peritonitis by a gradually growing E. coli load and how these kinetics may affect outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21690093      PMCID: PMC3196080          DOI: 10.1074/jbc.M110.189126

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  A family of cytokine-inducible inhibitors of signalling.

Authors:  R Starr; T A Willson; E M Viney; L J Murray; J R Rayner; B J Jenkins; T J Gonda; W S Alexander; D Metcalf; N A Nicola; D J Hilton
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

2.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

Review 3.  Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

4.  Interleukin-18 facilitates the early antimicrobial host response to Escherichia coli peritonitis.

Authors:  Sebastiaan Weijer; Miguel E Sewnath; Alex F de Vos; Sandrine Florquin; Koen van der Sluis; Dirk J Gouma; Kiyoshi Takeda; Shizuo Akira; Tom van der Poll
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

5.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

6.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

Authors:  O Adachi; T Kawai; K Takeda; M Matsumoto; H Tsutsui; M Sakagami; K Nakanishi; S Akira
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

7.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

Review 8.  Intraabdominal infection: a review.

Authors:  K L McClean; G J Sheehan; G K Harding
Journal:  Clin Infect Dis       Date:  1994-07       Impact factor: 9.079

9.  Intraabdominal infections: classification, mortality, scoring and pathophysiology.

Authors:  R G Holzheimer; K H Muhrer; N L'Allemand; T Schmidt; K Henneking
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

10.  MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.

Authors:  R Shimazu; S Akashi; H Ogata; Y Nagai; K Fukudome; K Miyake; M Kimoto
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more
  16 in total

1.  Cathelicidins Inhibit Escherichia coli-Induced TLR2 and TLR4 Activation in a Viability-Dependent Manner.

Authors:  Maarten Coorens; Viktoria A F Schneider; A Marit de Groot; Albert van Dijk; Marjolein Meijerink; Jerry M Wells; Maaike R Scheenstra; Edwin J A Veldhuizen; Henk P Haagsman
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

2.  Abdominal Distension and Escherichia coli Peritonitis in Mice Lacking Myeloid Differentiation Factor 88.

Authors:  Linda K Johnson; Antin Yn Widi; Serrin Rowarth; Alan G Baxter
Journal:  Comp Med       Date:  2015-04       Impact factor: 0.982

3.  TLR4 inhibition impairs bacterial clearance in a therapeutic setting in murine abdominal sepsis.

Authors:  Miriam H P van Lieshout; Tom van der Poll; Cornelis van't Veer
Journal:  Inflamm Res       Date:  2014-08-15       Impact factor: 4.575

4.  The GPCR adaptor protein norbin suppresses the neutrophil-mediated immunity of mice to pneumococcal infection.

Authors:  Chiara Pantarelli; Dingxin Pan; Stephen Chetwynd; Anne-Katrien Stark; Kirsti Hornigold; Polly Machin; Laraine Crossland; Simon J Cleary; Martin J Baker; Elizabeth Hampson; Anna Mandel; Anne Segonds-Pichon; Rachael Walker; Cornelis van 't Veer; Yanira Riffo-Vasquez; Klaus Okkenhaug; Simon Pitchford; Heidi C E Welch
Journal:  Blood Adv       Date:  2021-08-24

5.  Bruton's Tyrosine Kinase Deficiency Ameliorates Antimicrobial Host Defense during Peritonitis Induced by Pathogenic Escherichia coli.

Authors:  Zhe Liu; Cornelis van 't Veer; Rudi W Hendriks; Joris J T H Roelofs; Tom van der Poll; Alex F de Vos
Journal:  Infect Immun       Date:  2022-05-19       Impact factor: 3.609

6.  Resistance of the brain to Escherichia coli K1 infection depends on MyD88 signaling and the contribution of neutrophils and monocytes.

Authors:  Sandra Ribes; Tommy Regen; Tanja Meister; Simone C Tauber; Sandra Schütze; Alexander Mildner; Matthias Mack; Uwe-Karsten Hanisch; Roland Nau
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

7.  Limited role of nuclear receptor Nur77 in Escherichia coli-induced peritonitis.

Authors:  Anouk A J Hamers; Sven Uleman; Claudia M van Tiel; Daniëlle Kruijswijk; Anne-Marieke van Stalborch; Stephan Huveneers; Carlie J M de Vries; Cornelis van 't Veer
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

8.  Triggering receptor expressed on myeloid cells-2 fine-tunes inflammatory responses in murine Gram-negative sepsis.

Authors:  Riem Gawish; Rui Martins; Benedikta Böhm; Terje Wimberger; Omar Sharif; Karin Lakovits; Mariane Schmidt; Sylvia Knapp
Journal:  FASEB J       Date:  2014-12-04       Impact factor: 5.191

9.  Differential Toll-Like Receptor-Signalling of Burkholderia pseudomallei Lipopolysaccharide in Murine and Human Models.

Authors:  Tassili A F Weehuizen; Joann L Prior; Thomas W van der Vaart; Sarah A Ngugi; Sergey A Nepogodiev; Robert A Field; Liesbeth M Kager; Cornelis van 't Veer; Alex F de Vos; W Joost Wiersinga
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

10.  Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system.

Authors:  Florence B Gilbert; Patricia Cunha; Kirsty Jensen; Elizabeth J Glass; Gilles Foucras; Christèle Robert-Granié; Rachel Rupp; Pascal Rainard
Journal:  Vet Res       Date:  2013-06-11       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.